BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21074412)

  • 1. MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck.
    Luangdilok S; Box C; Harrington K; Rhŷs-Evans P; Eccles S
    Eur J Cancer; 2011 Mar; 47(4):520-9. PubMed ID: 21074412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
    Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
    Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
    Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
    Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metadherin regulation of vascular endothelial growth factor expression is dependent upon the PI3K/Akt pathway in squamous cell carcinoma of the head and neck.
    Zhu GC; Yu CY; She L; Tan HL; Li G; Ren SL; Su ZW; Wei M; Huang DH; Tian YQ; Su RN; Liu Y; Zhang X
    Medicine (Baltimore); 2015 Feb; 94(6):e502. PubMed ID: 25674742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways.
    Pickhard AC; Margraf J; Knopf A; Stark T; Piontek G; Beck C; Boulesteix AL; Scherer EQ; Pigorsch S; Schlegel J; Arnold W; Reiter R
    BMC Cancer; 2011 Sep; 11():388. PubMed ID: 21896192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
    Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
    Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.
    Masuda M; Suzui M; Lim JT; Deguchi A; Soh JW; Weinstein IB
    J Exp Ther Oncol; 2002; 2(6):350-9. PubMed ID: 12440226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [EphA2 mediated vascular endothelial growth factor expression via the p38 MAPK signaling pathway in squamous cell carcinoma of the head and neck].
    Liu Y; Tan HL; Li G; Yu CY; Su ZW; Ren SL; Zhu GC; Qiu YZ; Tian YQ; Zhang X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Mar; 48(3):229-33. PubMed ID: 23755789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis.
    Leelahavanichkul K; Amornphimoltham P; Molinolo AA; Basile JR; Koontongkaew S; Gutkind JS
    Mol Oncol; 2014 Feb; 8(1):105-18. PubMed ID: 24216180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK.
    Summy JM; Trevino JG; Baker CH; Gallick GE
    Pancreas; 2005 Oct; 31(3):263-74. PubMed ID: 16163059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway.
    Villaume K; Blanc M; Gouysse G; Walter T; Couderc C; Nejjari M; Vercherat C; Cordier-Bussat M; Roche C; Scoazec JY
    Neuroendocrinology; 2010; 91(3):268-78. PubMed ID: 20389030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
    Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
    Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pomolic acid suppresses HIF1α/VEGF-mediated angiogenesis by targeting p38-MAPK and mTOR signaling cascades.
    Park JH; Yoon J; Park B
    Phytomedicine; 2016 Dec; 23(14):1716-1726. PubMed ID: 27912873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HB-EGF-induced VEGF production and eNOS activation depend on both PI3 kinase and MAP kinase in HaCaT cells.
    Nakai K; Yoneda K; Moriue T; Igarashi J; Kosaka H; Kubota Y
    J Dermatol Sci; 2009 Sep; 55(3):170-8. PubMed ID: 19559571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis.
    Kobayashi S; Kishimoto T; Kamata S; Otsuka M; Miyazaki M; Ishikura H
    Cancer Sci; 2007 May; 98(5):726-33. PubMed ID: 17425689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
    Mohan S; Vander Broek R; Shah S; Eytan DF; Pierce ML; Carlson SG; Coupar JF; Zhang J; Cheng H; Chen Z; Van Waes C
    Clin Cancer Res; 2015 Sep; 21(17):3946-56. PubMed ID: 25977343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol 3'-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells.
    Woods SA; McGlade CJ; Guha A
    Neuro Oncol; 2002 Oct; 4(4):242-52. PubMed ID: 12356354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma.
    Franchi A; Massi D; Santucci M; Masini E; Rossi Degl'Innocenti D; Magnelli L; Fanti E; Naldini A; Ardinghi C; Carraro F; Gallo O
    J Pathol; 2006 Feb; 208(3):439-45. PubMed ID: 16278821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia and EGF Stimulation Regulate VEGF Expression in Human Glioblastoma Multiforme (GBM) Cells by Differential Regulation of the PI3K/Rho-GTPase and MAPK Pathways.
    Nicolas S; Abdellatef S; Haddad MA; Fakhoury I; El-Sibai M
    Cells; 2019 Nov; 8(11):. PubMed ID: 31698752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.